1158219-47-6 Usage
Chemical structure
The compound consists of a piperidine ring with an amino group and a chlorobenzyl group attached to it.
Salt form
The dihydrochloride form indicates that the compound has two hydrogen chloride (HCl) molecules associated with it.
Storage and transport
The dihydrochloride form is a common way to store and transport certain drugs or chemicals due to its stability.
Pharmaceutical properties
1-(o-chlorobenzyl)-4-aminopiperidine dihydrochloride may have pharmaceutical properties, making it a potential candidate for drug development.
Potential applications
The compound could be used in the development of new drugs or treatments, depending on its specific properties and effects.
Safety precautions
It is important to handle 1-(o-chlorobenzyl)-4-aminopiperidine dihydrochloride with care and follow proper safety protocols due to its potential reactivity and toxicity.
Reactivity
The compound may be reactive with certain substances, so it is crucial to store and handle it appropriately to prevent unwanted reactions.
Toxicity
The compound may have toxic effects, and its specific toxicity level should be determined through further research and testing.
Research and development
Further studies are needed to fully understand the properties, potential applications, and safety of 1-(o-chlorobenzyl)-4-aminopiperidine dihydrochloride.
Check Digit Verification of cas no
The CAS Registry Mumber 1158219-47-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,8,2,1 and 9 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1158219-47:
(9*1)+(8*1)+(7*5)+(6*8)+(5*2)+(4*1)+(3*9)+(2*4)+(1*7)=156
156 % 10 = 6
So 1158219-47-6 is a valid CAS Registry Number.
1158219-47-6Relevant articles and documents
Aromatic amides of heterocyclic compounds and therapeutic compositions containing same
-
, (2008/06/13)
The invention relates to aromatic amides N-substituted by heterocyclic groups. More particularly, the invention relates to substituted benzoic acid amides of 1-arylalkylamino or aminoalkyl-N-heterocyclic rings and to pharmaceutical compositions thereof, which have the ability to antagonize the effects of dopamine or dopaminergic agents of endogenous or exogenous origin and which may be used for the treatment of nausea and vomiting resulting from gastrointestinal disorders, congestive heart failure, post operative conditions, etc., other gastrointestinal disorders such as dyspepsia, flatulence, bile regurgitations, hiatus hernia, peptic ulcer, reflux aerophagitis, gastritis, duodenitis, and cholethiasis, and a variety of conditions affecting the central nervous system such as acute and chronic psychoses, maniacal psychosis, schizophrenias, serious disturbances of behavior and non-melancholic depressive state and migraine.
